Open letter to Biogen following SMC recommendation
Another potential treatment for SMA is progressing fast
Biogen's statement re. Scottish decision on nusinersen availability
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Australia will allocate 240 million Australian dollars to fund the break-through Spinraza treatment for those with spinal muscular atrophy.
Below is an outline of the regulatory appraisal process of Spinraza in England and Wales.
TreatSMA is looking for a trustee!
A new Standard of Care in spinal muscular atrophy has been published.